Drugs / SAR113244
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02331810 | Apr 2016 → May 2017 | systemic lupus erythematosus | Sanofi | Withdrawn | No outcome recorded |
| Phase 1 | NCT02321709 | Nov 2014 → Mar 2016 | systemic lupus erythematosus | Sanofi | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SAR113244 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02321709 ↗ |
| Route | Subcutaneous | “Route of administration: subcutaneous” NCT02321709 ↗ |